Anti-PSG7/ PSBG-7/ PSG1 monoclonal antibody

Anti-PSG7/ PSBG-7/ PSG1 antibody for FACS & in-vivo assay

Target products collectionGo to PSG7/PSG7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2566-Ab-1/ GM-Tg-hg-MP2566-Ab-2Anti-Human PSG7 monoclonal antibodyHuman
GM-Tg-rg-MP2566-Ab-1/ GM-Tg-rg-MP2566-Ab-2Anti-Rat PSG7 monoclonal antibodyRat
GM-Tg-mg-MP2566-Ab-1/ GM-Tg-mg-MP2566-Ab-2Anti-Mouse PSG7 monoclonal antibodyMouse
GM-Tg-cynog-MP2566-Ab-1/ GM-Tg-cynog-MP2566-Ab-2Anti-Cynomolgus/ Rhesus macaque PSG7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2566-Ab-1/ GM-Tg-felg-MP2566-Ab-2Anti-Feline PSG7 monoclonal antibodyFeline
GM-Tg-cang-MP2566-Ab-1/ GM-Tg-cang-MP2566-Ab-2Anti-Canine PSG7 monoclonal antibodyCanine
GM-Tg-bovg-MP2566-Ab-1/ GM-Tg-bovg-MP2566-Ab-2Anti-Bovine PSG7 monoclonal antibodyBovine
GM-Tg-equg-MP2566-Ab-1/ GM-Tg-equg-MP2566-Ab-2Anti-Equine PSG7 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2566-Ab-1/ GM-Tg-hg-MP2566-Ab-2; GM-Tg-rg-MP2566-Ab-1/ GM-Tg-rg-MP2566-Ab-2;
GM-Tg-mg-MP2566-Ab-1/ GM-Tg-mg-MP2566-Ab-2; GM-Tg-cynog-MP2566-Ab-1/ GM-Tg-cynog-MP2566-Ab-2;
GM-Tg-felg-MP2566-Ab-1/ GM-Tg-felg-MP2566-Ab-2; GM-Tg-cang-MP2566-Ab-1/ GM-Tg-cang-MP2566-Ab-2;
GM-Tg-bovg-MP2566-Ab-1/ GM-Tg-bovg-MP2566-Ab-2; GM-Tg-equg-MP2566-Ab-1/ GM-Tg-equg-MP2566-Ab-2
Products NameAnti-PSG7 monoclonal antibody
Formatmab
Target NamePSG7
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PSG7 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PSG7/ PSBG-7/ PSG1 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-MP2566
    Target NamePSG7
    Gene ID5676
    Gene Symbol and SynonymsPS-beta-G-7,PSBG-7,PSG1,PSG7,PSGGA
    Uniprot AccessionQ13046
    Uniprot Entry NamePSG7_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000221878
    Target ClassificationN/A

    The target: PSG7, gene name: PSG7, also named as PSBG-7, PSG1, PSGGA. This gene is a member of the pregnancy-specific glycoprotein (PSG) gene family. The PSG genes are a subgroup of the carcinoembryonic antigen (CEA) family of immunoglobulin-like genes, and are found in a gene cluster at 19q13.1-q13.2 telomeric to another cluster of CEA-related genes. The PSG genes are expressed by placental trophoblasts and released into the maternal circulation during pregnancy, and are thought to be essential for maintenance of normal pregnancy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.